J. Kaye
Natural Language Processing · 2004–2019
A researcher in the Science corpus: 12 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Natural Language Processing — 5 citations into it
Whom J. Kaye trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- Eugene Charniak (in Natural Language Processing)
Papers from J. Kaye's perspective
Ordered by how strongly the researchers J. Kaye trusts endorse each paper. Same corpus, a different order for every researcher.
- A Maximum-Entropy-Inspired Parser
- Neuropathological stageing of Alzheimer-related changes
- Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory (Journal of Neuroscience)
- Amyloid Plaques Disrupt Resting State Default Mode Network Connectivity in Cognitively Normal Elderly (Biological Psychiatry)
- Alzheimer disease in the US population: prevalence estimates using the 2000 census. (Archives of Neurology)
- Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia (Proceedings of the National Academy of Sciences of the United States of America)
- Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis (Science)
- Distinct patterns of brain activity in young carriers of the APOE-ε4 allele (Proceedings of the National Academy of Sciences of the United States of America)
- Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade (Lancet Neurology)
- Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly (Archives of Neurology)
Their papers
- Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease (2011) — 1,887 citations
- Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins (2007) — 1,096 citations
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) — 2,422 citations
- Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis (2016) — 1,062 citations
- Spoken Language Derived Measures for Detecting Mild Cognitive Impairment (2011) — 352 citations
- Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease (2011) — 6,812 citations
- The aging systemic milieu negatively regulates neurogenesis and cognitive function (2011) — 1,032 citations
- Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions (2010) — 595 citations
- Neuropathology of Nondemented Aging: Presumptive Evidence for Preclinical Alzheimer Disease (2009) — 686 citations
- The status of computerized cognitive testing in aging: A systematic review (2008) — 426 citations
- Vitamin E and donepezil for the treatment of mild cognitive impairment. (2005) — 1,796 citations
- Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. (2004) — 994 citations